Vincent Paul Liptak Buys $74.7K of BlossomHill Therapeutics Inc (BLSM) — SEC Form 4, Aug 10, 2026
Open-Market Net Purchase · SEC Form 4
+$74,700
Equity position changed by +25.7%
Equity Position
134K sh
106,712 → 134,099
Equity Change
+25.7%
shares held after vs before
Filing Lag
0 business days
within 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership
Reporting Owner
| Name | Relationship |
|---|---|
| Vincent Paul Liptak CIK 0002143905 |
GC
|
Vincent Paul Liptak at BlossomHill Therapeutics Inc
Full insider history
Bought (12 mo)
$74,700
Sold (12 mo)
—
Non-Derivative Securities Transactions
| Title | Date | Type | Shares | Price | Net Total | Post-Txn | Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | 2026-08-07 | P - Purchase | 2,500 A | $15.80 | +$39,500 | 109,212 | Direct |
| Common Stock | 2026-08-10 | P - Purchase | 2,200 A | $16.00 | +$35,200 | 111,412 | Direct |
| Common StockF1F2 | 2026-08-10 | C - Conversion | 22,687 A | — | 22,687 | Indirect By Walter T. Liptak Revocable Trust |
Derivative Securities Transactions
| Title | Strike | Date | Type | Shares | Price | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F3 | $16.00 | 2026-08-06 | A - Award/Grant | 46,561 A | $0.00 | 2036-08-05 | 46,561 Common Stock | Direct |
| Series B Preferred StockF1F1F1F1F2 | 2026-08-10 | C - Conversion | 22,687 D | 22,687 Common Stock | Indirect By Walter T. Liptak Revocable Trust |
Footnotes (3)
- F1
- Each share of Series B Preferred Stock (the "Preferred Stock") automatically converted into 1 share of Common Stock upon the closing of the Issuer's initial public offering without payment of further consideration. The Preferred Stock had no expiration date. Show more
- F2
- The Reporting Person is a co-beneficiary and co-trustee of the Walter T. Liptak Revocable Trust (the "Trust") and has voting and dispositive power over the securities held by the Trust. Show more
- F3
- 1/4th of the shares subject to the option shall vest on August 6, 2027, and the balance of the shares shall vest in equal monthly installments over the following 36 months. Show more
Related filings at BlossomHill Therapeutics Inc
5%+ Holders · 13D/G
4 filers
Other insiders at BlossomHill Therapeutics Inc
GET /v1/forms/4/0002143905-26-000003
API docs
View Original SEC Filing